Adipose-Derived Mesenchymal Stromal Cells Treated with Interleukin 1 Beta Produced Chondro-Protective Vesicles Able to Fast Penetrate in Cartilage.
Adipose Tissue
/ metabolism
Adult
Cartilage, Articular
/ metabolism
Chondrocytes
/ metabolism
Collagen
/ chemistry
Computational Biology
Extracellular Vesicles
/ metabolism
Female
Humans
Image Processing, Computer-Assisted
Inflammation
Interleukin-1beta
/ metabolism
Kinetics
Male
Mesenchymal Stem Cells
/ cytology
MicroRNAs
/ metabolism
Middle Aged
Osteoarthritis
/ metabolism
Spectrometry, Fluorescence
Spectrum Analysis, Raman
adipose-derived mesenchymal stromal cells
cartilage
extracellular vesicles
interleukin 1 beta
miRNA
nonlinear optical microscopy
osteoarthritis
time-lapse
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
12 05 2021
12 05 2021
Historique:
received:
27
04
2021
revised:
07
05
2021
accepted:
09
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
26
10
2021
Statut:
epublish
Résumé
The study of the miRNA cargo embedded in extracellular vesicles (EVs) released from adipose-derived mesenchymal stromal cells (ASC) preconditioned with IL-1β, an inflammatory stimulus driving osteoarthritis (OA), along with EVs-cartilage dynamic interaction represent poorly explored fields and are the purpose of the present research. ASCs were isolated from subcutaneous adipose tissue and EVs collected by ultracentrifugation. Shuttled miRNAs were scored by high-throughput screening and analyzed through bioinformatics approach that predicted the potentially modulated OA-related pathways. Fluorescently labeled EVs incorporation into OA cartilage explants was followed in vitro by time-lapse coherent anti-Stokes Raman scattering; second harmonic generation and two-photon excited fluorescence. After IL-1β preconditioning, 7 miRNA were up-regulated, 4 down-regulated, 37 activated and 17 silenced. Bioinformatics allowed to identify miRNAs and target genes mainly involved in Wnt, Notch, TGFβ and Indian hedgehog (IHH) pathways, cartilage homeostasis, immune/inflammatory responses, cell senescence and autophagy. As well, ASC-EVs steadily diffuse in cartilage cells and matrix, reaching a plateau 16 h after administration. Overall, ASCs preconditioned with IL-1β allows secretion of EVs embedded with a chondro-protective miRNA cargo, able to fast penetrate in collagen-rich areas of cartilage with tissue saturation in a day. Further functional studies exploring the EVs dose-effects are needed to achieve clinical relevance.
Identifiants
pubmed: 34066077
pii: cells10051180
doi: 10.3390/cells10051180
pmc: PMC8151616
pii:
doi:
Substances chimiques
IL1B protein, human
0
Interleukin-1beta
0
MicroRNAs
0
Collagen
9007-34-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Italian Ministry of Health
ID : Ricerca Corrente
Références
Ann Rheum Dis. 2015 Mar;74(3):e18
pubmed: 24515954
Tissue Eng Part B Rev. 2019 Feb;25(1):55-77
pubmed: 30165783
Methods Mol Biol. 2012;822:261-72
pubmed: 22144205
Cytotherapy. 2019 Dec;21(12):1179-1197
pubmed: 31784241
Gene. 2011 Jul 1;480(1-2):34-41
pubmed: 21397669
Cell Commun Signal. 2019 Aug 16;17(1):97
pubmed: 31420042
Pharmaceutics. 2020 Aug 05;12(8):
pubmed: 32764234
Arthritis Rheum. 2006 Jul;54(7):2152-63
pubmed: 16802353
J Clin Med. 2019 Mar 28;8(4):
pubmed: 30925656
Mol Cells. 2014 Jun;37(6):449-56
pubmed: 24916040
PLoS One. 2008;3(11):e3740
pubmed: 19011694
Mol Med Rep. 2017 Jun;15(6):4391-4397
pubmed: 28487981
BMC Musculoskelet Disord. 2012 Aug 12;13:144
pubmed: 22883423
Biomolecules. 2020 Sep 22;10(9):
pubmed: 32971982
BMC Bioinformatics. 2019 Nov 4;20(1):545
pubmed: 31684860
Arthritis Res Ther. 2012 Apr 16;14(2):R75
pubmed: 22507670
J Orthop Surg Res. 2017 Mar 28;12(1):51
pubmed: 28351380
Int J Mol Med. 2014 Aug;34(2):451-63
pubmed: 24939082
Arthritis Res Ther. 2020 Jan 2;22(1):2
pubmed: 31898522
Stem Cell Res Ther. 2019 Mar 29;10(1):109
pubmed: 30922413
Curr Rheumatol Rep. 2016 Aug;18(8):56
pubmed: 27402113
Eur Cell Mater. 2014 Apr 23;27:298-311
pubmed: 24760577
Osteoarthritis Cartilage. 2016 Apr;24(4):573-80
pubmed: 26576510
PLoS One. 2013 Sep 09;8(9):e75012
pubmed: 24040378
Int J Mol Med. 2014 Jul;34(1):13-23
pubmed: 24736803
Arthritis Rheum. 2009 Apr;60(4):1035-41
pubmed: 19333945
Arthritis Rheum. 2013 Dec;65(12):3141-52
pubmed: 24022470
Stem Cell Res Ther. 2020 Dec 14;11(1):539
pubmed: 33317598
Exp Mol Med. 2016 Jun 24;48:e241
pubmed: 27339399
Osteoarthritis Cartilage. 2016 Sep;24(9):1577-86
pubmed: 27143365
Int J Mol Sci. 2017 Nov 22;18(11):
pubmed: 29165387
Int J Mol Sci. 2020 Feb 26;21(5):
pubmed: 32111031
Front Bioeng Biotechnol. 2021 Feb 15;9:632440
pubmed: 33659243
Int J Mol Sci. 2019 Sep 05;20(18):
pubmed: 31492046
J Immunol. 2007 Oct 15;179(8):5082-9
pubmed: 17911593
Pol Przegl Chir. 2019 Feb 6;91(3):1-5
pubmed: 31243168
Int J Biol Macromol. 2013 Oct;61:43-9
pubmed: 23791756
Osteoarthritis Cartilage. 2009 Apr;17(4):464-72
pubmed: 19008124
Stem Cell Res Ther. 2020 Apr 28;11(1):165
pubmed: 32345351
Arthritis Rheum. 2010 May;62(5):1361-71
pubmed: 20131257
Knee Surg Sports Traumatol Arthrosc. 2019 Jun;27(6):2003-2020
pubmed: 30159741
Arthritis Rheum. 2012 Jun;64(6):1697-707
pubmed: 22392533
Rheumatol Int. 2006 Aug;26(10):900-3
pubmed: 16468044
Arthritis Rheum. 2008 Apr;58(4):1001-9
pubmed: 18383392
Cell Signal. 2019 Jan;53:212-223
pubmed: 30312659